StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
SCHOTT Pharma AG & Co. KGaA
Frankfurt Stock Exchange:1SXP.F
Sector
Location
Market Cap
USD 4.55 B
Share Price
USD 30.15
Avg Daily Volume
165
Change (1 day)
-0.78%
Change (1 year)
-16.71%
Change (YTD)
15.16%
SCHOTT Pharma AG & Co. KGaA EBIT Margin for the year ending September 30, 2024: 20.63%
SCHOTT Pharma AG & Co. KGaA EBIT Margin is 20.63% for the year ending September 30, 2024, a 5.46% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
SCHOTT Pharma AG & Co. KGaA EBIT Margin for the year ending September 30, 2023 was 19.56%, a 8.74% change year over year.
-
SCHOTT Pharma AG & Co. KGaA EBIT Margin for the year ending September 30, 2022 was 17.99%, a 5.11% change year over year.
-
SCHOTT Pharma AG & Co. KGaA EBIT Margin for the year ending September 30, 2021 was 17.12%, a 9.31% change year over year.
-
SCHOTT Pharma AG & Co. KGaA EBIT Margin for the year ending September 30, 2020 was 15.66%.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
West Pharmaceutical Services, Inc.
USD 224.49
WST
-2.69
-1.18%
Yuhan Corporation
USD 81.73
000100.KS
+1.63
2.04%
Gan & Lee Pharmaceuticals.
USD 7.81
603087.SS
+0.02
0.27%
Cohance Lifesciences Limited
USD 12.21
COHANCE.NS
+0.22
1.83%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.93
600521.SS
+0.06
2.07%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.11
600867.SS
-0.00
-0.27%
Anbio Biotechnology Class A Ordinary Shares
USD 47.66
NNNN
-1.60
-3.25%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.26
300009.SZ
+0.01
0.42%
Neuland Laboratories Limited
USD 173.76
NEULANDLAB.NS
+4.59
2.71%
Qingdao Baheal Medical Inc.
USD 2.95
301015.SZ
-0.01
-0.40%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
West Pharmaceutical Services, Inc.
USD 224.49
WST
-2.69
-1.18%
Yuhan Corporation
USD 81.73
000100.KS
+1.63
2.04%
Gan & Lee Pharmaceuticals.
USD 7.81
603087.SS
+0.02
0.27%
Cohance Lifesciences Limited
USD 12.21
COHANCE.NS
+0.22
1.83%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 2.93
600521.SS
+0.06
2.07%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.11
600867.SS
-0.00
-0.27%
Anbio Biotechnology Class A Ordinary Shares
USD 47.66
NNNN
-1.60
-3.25%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.26
300009.SZ
+0.01
0.42%
Neuland Laboratories Limited
USD 173.76
NEULANDLAB.NS
+4.59
2.71%
Qingdao Baheal Medical Inc.
USD 2.95
301015.SZ
-0.01
-0.40%
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%